Global Clinical Outsourcing Industry Report

By:
Posted: 02/20/2013

The number of clinical trials being outsourced is increasing and the industry is working together to develop ground-breaking partnerships that focus on creative contracting and effective oversight.

According to a recent report, more than a third of clinical trials conducted by Pharma organisations are now being outsourced to vendors and expenditure on clinical trial outsourcing has also increased with the amount of global research and development expenditure allotted to the outsourced drug developers reaching $36.6 billion last year. Whether you are a big Pharma organisation or small Biotech, the relationship between sponsor and CRO is crucial to maximise the efficiency of clinical trials.

This whitepaper gives you an up-to-date overview of the evolving nature of the outsourcing market and points to the challenges and opportunities that working with a CRO can bring. Case studies and included videos deliver industry best-practice and experiences on how to nurture and prosper from a successful relationship with your CRO.
 

To continue viewing this content please fill out the form below and become an Pharma IQ member.
Or if you're already a Pharma IQ member, sign in below to download.
Join

By entering in your information and submitting the form, you give the sponsor permission to contact you regarding their product and you agree to our User Agreement, Privacy Policy, and Cookie Policy.

By:
Posted: 02/20/2013

Pharma IQ Members